Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: The stroke acute management with urgent risk factor assessment and improvement rt-PA registry

Cerebrovascular Diseases

Volumn 34, Issue 2, 2012, Pages 140-146

  Mori, Mayumi ^a,b   Naganuma, Masaki ^a   Okada, Yasushi ^b   Hasegawa, Yasuhiro ^c   Shiokawa, Yoshiaki ^d   Nakagawara, Jyoji ^e   Furui, Eisuke ^f   Kimura, Kazumi ^g   Yamagami, Hiroshi ^h   Kario, Kazuomi ⁱ   Okuda, Satoshi ^j   Koga, Masatoshi ^a   Minematsu, Kazuo ^a   Toyoda, Kazunori ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Nakamura Memorial Hospital   (Japan)

^f KOHNAN HOSPITAL   (Japan)

^g KAWASAKI MEDICAL SCHOOL   (Japan)

^h KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

ⁱ JICHI MEDICAL UNIVERSITY   (Japan)

^j NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

more..

Author keywords

Acute ischemic stroke; Diabetes mellitus; Hyperglycemia; Intracerebral hemorrhage; Thrombolysis; Tissue plasminogen activator

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; STROKE; STROKE PATIENT; TREATMENT DURATION; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BRAIN DAMAGE, CHRONIC; COMORBIDITY; DIABETES COMPLICATIONS; DISEASE PROGRESSION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; INPATIENTS; JAPAN; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84864414562     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000339759     Document Type: Article

References (30)

1. Alawneh JA, Moustafa RR, Baron JC: Hemodynamic factors and perfusion abnormalities in early neurological deterioration. Stroke 2009; 40:e443-e450.
2. DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ: Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. Stroke 1999; 30: 1208-1212.
3. Tei H, Uchiyama S, Ohara K, Kobayashi M, Uchiyama Y, Fukuzawa M: Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke 2000; 31: 2049-2054.
4. Weimar C, Mieck T, Buchthal J, Ehrenfeld CE, Schmid E, Diener HC, German Stroke Study Collaboration: Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol 2005; 62: 393-397.
5. Davalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J: Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I. Stroke 1999; 30: 2631-2636.
6. Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, Levine SR, Lyden PD, NINDS rt-PA Stroke Study Group: Clinical deterioration following improvement in the NINDS rt-PA stroke trial. Stroke 2001; 32: 661-668.
7. Jorgensen HS, Nakayama H, Olsen TS, Raaschou HO: Effect of blood pressure and diabetes on stroke in progression. Lancet 1994; 344: 156-159.
8. Davalos A, Cendra E, Teruel J, Martinez M, Genis D: Deteriorating ischemic stroke: risk factors and prognosis. Neurology 1990; 40: 1865-1869.
9. Leigh R, Zaidat OO, Suri MF, Lynch G, Sundararajan S, Sunshine JL, Tarr R, Selman W, Landis DMD, Suarez JI: Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 2004; 35: 1903-1907.
10. Awadh M, MacDougall N, Santosh C, Teasdale E, Baird T, Muir KW: Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation. Stroke 2010; 41: 1990-1995.
11. Georgiadis D, Engelter S, Tettenborn B, Hungerbuhler H, Luethy R, Muller F, Arnold M, Giambarba C, Baumann CR, Budingen HC, Lyrer P, Baumgartner RW: Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysis. Circulation 2006; 114: 237-241.
12. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, Kummer R, Wahlgren N, Toni D, ECASS Investigation: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
13. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
14. Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Davalos A, Erila T, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kohrmann M, Larrue V, Lees KR, Machnig T, Roine RO, Toni D, Vanhooren G, SITSMOST Investigators: Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008; 39: 3316-3322.
15. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EFM: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655-1711.
16. Toyoda K, Koga M, Naganuma M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K: Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI Register. Stroke 2009; 40: 3591-3595.
17. Nezu T, Koga M, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Naganuma M, Minematsu K, Toyoda K: Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA Registry. Neurology 2010; 75: 555-561.
18. Naganuma M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K, Toyoda K: Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA Registry. Cerebrovasc Dis 2011; 31: 123-129.
19. Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, Shinohara Y: Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 2006; 37: 1810-1815.
20. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III, TOAST Investigators: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
21. Barber PA, Demchuk AM, Zhang J, Buchan AM: Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000; 355: 1670-1674.
22. Nezu T, Koga M, Nakagawara J, Shiokawa Y, Yamagami H, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Minematsu K, Toyoda K: Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registry. Stroke 2011; 42: 2196-2200.
23. Koga M, Toyoda K, Nakashima T, Hyun BH, Uehara T, Yokota C, Nagatsuka K, Naritomi H, Minematsu K: Carotid duplex ultrasonography can predict outcome of intravenous alteplase therapy for hyperacute stroke. J Stroke Cerebrovasc Dis 2011; 20: 24-29.
24. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, Hennerici M, ECASS Study Group: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025.
25. Alvarez-Sabin J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, Codina A, Quintana M: Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 2003; 34: 1235-1241.
26. Alvarez-Sabin J, Molina CA, Ribo M, Arenillas JF, Montaner J, Huertas R, Santamarina E, Rubiera M: Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke 2004; 35: 2493-2498.
27. Lansberg MG, Albers GW, Wijman CA: Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis 2007; 24: 1-10.
28. Nakashima T, Toyoda K, Koga M, Matsuoka H, Nagatsuka K, Takada T, Naritomi H, Minematsu K: Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke. Int J Stroke 2009; 4: 425-431.
29. Diedler J, Ahmed N, Sykora M, Uyttenboogaart M, Overgaard K, Luijckx GJ, Soinne L, Ford GA, Lees KR, Wahlgren N, Ringleb P: Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke 2010; 41: 288-294.
30. The Helsinki Stroke Thrombolysis Registry Group: Cerebral edema in acute ischemic stroke patients treated with intravenous thrombolysis. Int J Stroke 2012, E-pub ahead of print.